Clinical efficacy and cost-benefit analysis of nocturnal home oxygen therapy in patients with central sleep apnea caused by chronic heart failure

Circulation Journal

Volumn 71, Issue 11, 2007, Pages 1738-1743

  Seino, Yoshihiko ^a   Imai, Hidehiko ^b   Nakamoto, Takaaki ^c   Araki, Yoshihiko ^d   Sasayama, Shigetake ^e  

^a NIPPON MEDICAL SCHOOL CHIBA HOKUSOH HOSPITAL   (Japan)

^b MUSASHI UNIVERSITY   (Japan)

^c DOKKYO MEDICAL UNIVERSITY   (Japan)

^d OSAKA PREFECTURAL MEDICAL CENTER FOR RESPIRATORY AND ALLERGIC DISEASES   (Japan)

^e DOSHISHA UNIVERSITY   (Japan)

Author keywords

Central sleep apnea; Cost benefit analysis; Heart failure; Home oxygen therapy; Hospitalization; Quality of life

Indexed keywords

CARVEDILOL; DIGOXIN; ENALAPRIL; FUROSEMIDE;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; COST BENEFIT ANALYSIS; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OXYGEN THERAPY; SENSITIVITY ANALYSIS; SLEEP APNEA SYNDROME; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; COST-BENEFIT ANALYSIS; EMERGENCY SERVICE, HOSPITAL; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOME CARE SERVICES; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; OXYGEN; OXYGEN INHALATION THERAPY; QUALITY OF LIFE; SLEEP APNEA, CENTRAL; STROKE VOLUME; TREATMENT OUTCOME;

EID: 36949037146     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.1738     Document Type: Article

References (28)

1. Hanly PJ, Zuberi-Khokhar NS. Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure. Am J Respir Crit Care Med 1996; 153: 272-276.
2. Lanfranchi PA, Braghiroli A, Bosimini E, Mazzuero G, Colombo R, Donner CF, et al. Prognostic value of nocturnal Chyene-Stokes respiration in chronic heart failure. Circulation 1999; 99: 1435-1440.
3. Sin DD, Logan AG, Fitzgerald FS, Liu PP, Bradley TD. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation 2000; 102: 61-66.
4. Bradley TD, Floras JS. Sleep apnea and heart failure. Part I: Obstructive sleep apnea. Circulation 2003; 107: 1671-1678.
5. Bradley TD, Floras JS. Sleep apnea and heart failure. Part II: Central sleep apnea. Circulation 2003; 107: 1822-1826.
6. Javaheri S, Parker TJ, Liming JD, Corbett WS, Nishiyama H, Wexler L, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure: Types and their prevalences, consequences, and presentations. Circulation 1998; 97: 2154-2159.
7. Sin DD, Fitsgerald F, Parker JD, Newton G, Floras JS, Bradley TD. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999; 160: 1101-1106.
8. Kaneko Y, Floras JS, Usui K, Plante J, Tkacova R, Kubo T, et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003; 348: 1233-1241.
9. Naughton MT, Benard DC, Liu PP, Rutherford R, Rankin F, Bradley TD. Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 1995; 152: 473-479.
10. Javaheri S. Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure. Circulation 2000; 101: 392-397.
11. Kasai T, Narui K, Dohi T, Ishiwata S, Yoshimura K, Nishiyama S, et al. Efficacy of nasal bi-level positive airway pressure in congestive heart failure patients with Cheyne-Stokes respiration and central sleep apnea. Circ J 2005; 69: 913-921.
12. Zhao ZH, Liu ZH, Luo Q, Xiong CM, Ni XH, Zhang J, et al. Positive pressure ventilation treatment reduces plasma levels of amino terminal-pro brain natriuretic peptide in congestive heart failure patients with sleep apnea. Circ J 2006; 70: 572-574.
13. Hanly PJ, Millar TW, Steljes DG, Baert R, Frais MA, Kryger MH. The effect of oxygen on respiration and sleep in patients with congestive heart failure. Ann Intern Med 1989; 111: 777-782.
14. Franklin KA, Eriksson P, Sahlin C, Lundgren R. Reversal of central sleep apnea with oxygen. Chest 1997; 111: 163-169.
15. 2 on sleep-related disordered breathing in ambulatory patients with stable heart failure. Sleep 1999; 22: 1101-1106.
16. Staniforth AD, Kinnear WJ, Starling R, Hetmanski DJ, Cowley AJ. Effect of oxygen on sleep quality, cognitive function and sympathetic activity in patients with chronic heart failure and Cheyne-Stokes respiration. Eur Heart J 1998; 19: 922-928.
17. Andreas S, Clemens C, Sandholzer H, Figulla HR, Kreuzer H. Improvement of exercise capacity with treatment of Cheyne-Stokes respiration in patients with congestive heart failure. J Am Coll Cardiol 1996; 27: 1486-1490.
18. Sasayama S, Izumi T, Seino Y, Ueshima K, Asanoi H; CHF-HOT Study Group. Effect of nocturnal oxygen therapy on outcome measures in patients with chronic heart failure and Cheyne-Stokes respiration. Circ J 2006; 70: 1-7.
19. Sasayama S, Asanoi H, Ishizaka S, Miyagi K. Evaluation of functional capacity of patients with congestive heart failure. In: Yasuda H, Kawaguchi H. editors. New aspects in the treatment of failing heart. Tokyo: Springer-Verlag; 1992; 113-117.
20. The EPOCH study group. Effects of pimobendan on adverse cardiac events and physical activities in patients with mild to moderate chronic heart failure: The effects of pimobendan on chronic heart failure study (EPOCH study). Circ J 2002; 66: 149-157.
21. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996; 334: 1349-1355.
22. CIBIS-II Investigators and Committees. The cardiac insufficiency bisoprolol study II (CIBIS-II): A randomized trial. Lancet 1999; 353: 9-13.
23. Hori M, Sasayama S, Kitabatake A, Toyo-oka T, Handa S, Yokoyama M, et al: MUCHA investigators. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: The Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial. Am Heart J 2004; 147: 324-330.
24. Ishihara H, Kimura K, Kakei T. Status and issues in home oxygen therapy in Japan. In: Report from the Research Committee on Respiratory Diseases Organized by the Ministry of Welfare, Japan. Tokyo. The Ministry; 2001; 68-71.
25. Miyamoto K, Kawakami Y, Tobita W, Hida W, Sato S, Suzuki E, et al. Usefulness in economical efficacy in home oxygen therapy. In: Report from the Research Committee on Respiratory Diseases Organized by the Ministry of Welfare, Japan. Tokyo: The Ministry; 1996: 15-17.
26. Bradley TD, Logan AG, Kimoff RJ, Sériès F, Morrison D, Ferguson K, et al. Continuous positive airway pressure tor central sleep apnea and heart failure. N Engl J Med 2005; 353: 2025-2033.
27. Marius-Nunez AL, Heaney L, Fernandez RN, Clark WA, Ranganini A, Silber E, et al. Intermittent inotropic therapy in an outpatient setting: A cost-effective therapeutic modality in patients with refractory heart failure. Am Heart J 1996; 132: 805-808.
28. Felker GM, Benza RL, Chandler AB, Leimberger JD, Cuffe MS. Califf RM, et al: OPTIME-CHF Investigators. Heart failure etiology and response to milrinone in decompensated heart failure: Results from the OPTIME-CHF study. J Am Coll Cardiol 2003; 41: 997-1003.